| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratory of Experimental Carcinogenesis and Metabolism, Roche Institute of Molecular Biology, Nutley, New Jersey 07110 [W. L., R. L. C., A. W. W., A. H. C.], and Laboratory of Bioorganic Chemistry, National Institute of Arthritis, Diabetes, and Digestive and Kidney Diseases, NIH, Bethesda, Maryland 20892 [D. R. T., H. Y., D. M. J.]
Tumorigenic activities of the (+)- and (-)-enantiomers of the diastereomeric, bay-region benzo(c)phenanthrene 3,4-diol-1,2-epoxides were evaluated in two mouse tumor models. In an initiation-promotion experiment on mouse skin, a single topical application of 10, 25, or 75 nmol of the compounds was followed by 20 weeks of promotion with 12-O-tetradecanoylphorbol-13-acetate. Of the four optical isomers of the bay-region diol epoxides, (-)-(1R,2S,3S,4R)-3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenzo(c)phenanthrene [(-)-diol epoxide-2] and (+)-(1R,2S,3R,4S)-3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenzo(c)phenanthrene [(+)-diol epoxide-1] had equally high tumor-initiating activity while (+)-[1S,2R,3R,4S]-3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenzo(c)phenanthrene [(+)-diol epoxide-2] had less than one-half of the activity of (-)-diol epoxide-2 and (+)-diol epoxide-1. (-)-(1S,2R,3S,4R)-3,4-Dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenzo(c)phenanthrene [(-)-diol epoxide-1] was inactive at the doses tested. In newborn mice, (-)-diol epoxide-2 was almost 10-fold more active in producing lung tumors (average number of lung tumors/mouse) than the next most active compound, (+)-diol epoxide-2, at a total dose of 10 nmol. The enantiomers of diol epoxide-1 were inactive at this dose. When the total dose of each optical isomer was increased to 50 nmol, (-)-diol epoxide-1 was still inactive, and (+)-diol epoxide-1 produced a significant number of lung tumors (0.9 lung tumor/mouse), but this isomer still had less than 10% of the activity of the (+)- and (-)-diol epoxide-2 isomers. (-)-Diol epoxide-2, but none of the other optical isomers, also produced a significant incidence of hepatic tumors at the higher dose, and this compound was found to be the most tumorigenic bay-region diol epoxide ever tested in newborn mice. Racemic diol epoxide-1 had approximately 1% of the tumorigenic activity of racemic diol epoxide-2 in newborn mice, but both recemates had equal tumor-initiating activity on mouse skin. These results dramatically illustrate the complexities involved in ranking the relative tumorigenic activities of compounds in different tumor models.
1 To whom requests for reprints should be addressed.
Received 11/11/85. Revised 1/23/86. Accepted 1/28/86.
This article has been cited by other articles:
|
|
 |
|
  V. K. Batra, D. D. Shock, R. Prasad, W. A. Beard, E. W. Hou, L. C. Pedersen, J. M. Sayer, H. Yagi, S. Kumar, D. M. Jerina, et al. Structure of DNA polymerase beta with a benzo[c]phenanthrene diol epoxide-adducted template exhibits mutagenic features PNAS, November 14, 2006; 103(46): 17231 - 17236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Graziewicz, J. M. Sayer, D. M. Jerina, and W. C. Copeland Nucleotide incorporation by human DNA polymerase {gamma} opposite benzo[a]pyrene and benzo[c]phenanthrene diol epoxide adducts of deoxyguanosine and deoxyadenosine Nucleic Acids Res., January 16, 2004; 32(1): 397 - 405. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. C. Driscoll, S. W. Matson, J. M. Sayer, H. Kroth, D. M. Jerina, and R. M. Brosh Jr. Inhibition of Werner Syndrome Helicase Activity by Benzo[c]phenanthrene Diol Epoxide dA Adducts in DNA Is Both Strand-and Stereoisomer-dependent J. Biol. Chem., October 17, 2003; 278(42): 41126 - 41135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Schinecker, R. A. Perlow, S. Broyde, N. E. Geacintov, and D. A. Scicchitano Human RNA polymerase II is partially blocked by DNA adducts derived from tumorigenic benzo[c]phenanthrene diol epoxides: relating biological consequences to conformational preferences Nucleic Acids Res., October 15, 2003; 31(20): 6004 - 6015. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wu, S. Yan, D. J. Patel, N. E. Geacintov, and S. Broyde Relating repair susceptibility of carcinogen-damaged DNA with structural distortion and thermodynamic stability Nucleic Acids Res., August 1, 2002; 30(15): 3422 - 3432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kumar, R. L. Chang, A. W. Wood, J. G. Xie, M. T. Huang, X. X. Cui, P. L. Kole, H. C. Sikka, S. K. Balani, A. H. Conney, et al. Tumorigenicity of racemic and optically pure bay region diol epoxides and other derivatives of the nitrogen heterocycle dibenz[a,h]acridine on mouse skin Carcinogenesis, June 1, 2001; 22(6): 951 - 955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Chang, A. W. Wood, S. Kumar, R. E. Lehr, N. Shirai, D. M. Jerina, and A. H. Conney Tumorigenicity of four optically active bay-region 3,4-diol 1,2-epoxides and other derivatives of the nitrogen heterocycle dibenz[c,h]acridine on mouse skin and in newborn mice Carcinogenesis, November 1, 2000; 21(11): 1997 - 2003. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Buterin, M. T. Hess, N. Luneva, N. E. Geacintov, S. Amin, H. Kroth, A. Seidel, and H. Naegeli Unrepaired Fjord Region Polycyclic Aromatic Hydrocarbon-DNA Adducts in ras Codon 61 Mutational Hot Spots Cancer Res., April 1, 2000; 60(7): 1849 - 1856. [Abstract] [Full Text]
|
|
|
|
|
|
M. Schiltz, X. X. Cui, Y.-P. Lu, H. Yagi, D. M. Jerina, M. Z. Zdzienicka, R. L. Chang, A. H. Conney, and S.-J.C. Wei Characterization of the mutational profile of (+)-7R,8S-dihydroxy-9S,10R-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene at the hypoxanthine (guanine) phosphoribosyltransferase gene in repair-deficient Chinese hamster V-H1 cells Carcinogenesis, December 1, 1999; 20(12): 2279 - 2286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Pal, A. Seidel, H. Xia, X. Hu, S. K. Srivastava, F. Oesch, and S. V. Singh Specificity of murine glutathione S- transferase isozymes in the glutathione conjugation of (–)- anti- and (+)-syn-stereoisomers of benzo[g]chrysene 11,12-diol 13,14-epoxide Carcinogenesis, October 1, 1999; 20(10): 1997 - 2001. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Hu, C. Herzog, P. Zimniak, and S. V. Singh Differential Protection against Benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide-induced DNA Damage in HepG2 Cells Stably Transfected with Allelic Variants of {{pi}} Class Human Glutathione S-Transferase Cancer Res., May 1, 1999; 59(10): 2358 - 2362. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
